IP Library Granted Patent US 10,278,585
Granted Patent B2
US 10,278,585 · App. 13/922,996 · Granted May 7, 2019

Quantification and analysis of angiography and perfusion

Inventors: T. Bruce Ferguson, Jr. (Raleigh, NC); Cheng Chen (Greenville, NC)
Assignee: NOVADAQ TECHNOLOGIES ULC
A61B5/0071A61B5/0261A61B5/0275A61K49/0034A61B2505/05A61B2576/023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,278,585
App. No.
13/922,996
Granted
May 7, 2019
Kind
B2
Abstract

A method to visualize, display, analyze and quantify angiography, perfusion, and the change in angiography and perfusion in real time, is provided. This method captures image data sequences from indocyanine green near infra-red fluorescence imaging used in a variety of surgical procedure applications, where angiography and perfusion are critical for intraoperative decisions.

Claims (31)

1. A method for visualizing blood flow in tissue before and after a surgical intervention, the method comprising:

receiving a first image data sequence from indocyanine green near-infrared fluorescence angiography (ICG-NIR-FA) comprising a plurality of fluorescence images of the tissue before the surgical intervention, wherein the first image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

deriving a first average intensity v. time curve from the first image data sequence;

receiving a second image data sequence from ICG-NIR-FA comprising a plurality of fluorescence images of the tissue after the surgical intervention, wherein the second image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

deriving a second average intensity v. time curve from the second image data sequence;

synchronizing the first and second average intensity v. time curves based on peak fluorescence intensities to align at least a portion of the full phase angiography cycle of the first image data sequence with the corresponding portion of the full angiography cycle of the second image data sequence;

determining, in real time, an amount of perfusion change in the tissue based on the synchronized curves; and

displaying, in real time, the synchronized average intensity v. time curves and the determined amount of perfusion change on a display.

2. The method of claim 1 , wherein the tissue is selected from the group consisting of myocardium during revascularization, breast tissue during reconstruction and bowel tissue during anastomosis.

3. The method of claim 1 , wherein the full phase angiography cycle of blood flow comprises an arterial phase, a microvascular phase, and a venous phase.

4. The method of claim 3 , wherein synchronizing the first and second image data sequences comprises correlating, between the first and second image data sequences, at least one of the arterial phase, microvascular phase, and venous phase.

5. The method of claim 1 , wherein synchronizing the first and second image data sequences comprises calculating a correlation coefficient at each alignment time position and synchronizing the first and second image data based on the largest correlation coefficient.

6. The method of claim 1 , wherein the tissue is a blood vessel.

7. The method of claim 6 , wherein the vessel is a coronary artery bypass graft.

8. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized curves comprises comparing relative fluorescence intensity between the synchronized first and second image data sequences.

9. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized curves comprises estimating a change of baseline fluorescence intensity difference over the synchronized first and second image data sequences, and adjusting the synchronized first and second image data sequences based on the change in baseline fluorescence intensity.

10. The method of claim 1 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized curves comprises estimating the perfusion level based on average fluorescence intensity above a threshold.

11. The method of claim 10 , wherein determining, in real time, an amount of perfusion change in the tissue based on the synchronized curves further comprises estimating the number of image pixels having fluorescence intensity above the threshold.

12. A system for visualizing blood flow in tissue before and after a surgical intervention, comprising:

a processor that

receives a first image data sequence from indocyanine green near-infrared fluorescence angiography (ICG-NIR-FA) comprising a plurality of fluorescence images of the tissue before the surgical intervention, wherein the first image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

derives a first average intensity v. time curve from the first image data sequence;

receives a second image data sequence from ICG-NIR-FA comprising a plurality of fluorescence images of the tissue after the surgical intervention, wherein the second image data sequence encompasses at least one full phase angiography cycle of blood flow through the tissue;

derives a second average intensity v. time curve from the second image data sequence;

synchronizes the first and second image data sequences average intensity v. time curves based on peak fluorescence intensities of average intensity vs. time curves of the first and second image data sequences to align at least a portion of the full phase angiography cycle of the first image data sequence with the corresponding portion of the full phase angiography cycle of the second image data sequence;

determines, in real time, an amount of perfusion change in the tissue based on the synchronized curves; and a display that displays, in real time, the synchronized average intensity v. time curves and the determined amount of perfusion change on a display.

13. The system of claim 12 , wherein the full angiography cycle of blood flow comprises an arterial phase, a microvascular phase, and a venous phase, and the processor synchronizes the first and second image data sequences by correlating, between the first and second image data sequences, at least one of the arterial phase, microvascular phase, and venous phase.

14. The system of claim 12 , wherein the processor synchronizes the first and second image data sequences by calculating a correlation coefficient at each alignment time position and synchronizing the first and second image data based on the largest correlation coefficient.

15. The system of claim 12 , wherein the tissue is a blood vessel and the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized curves by comparing relative fluorescence intensity between the synchronized first and second image data sequences.

16. The system of claim 12 , wherein the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized curves at least in part by estimating the perfusion level based on average fluorescence intensity above a threshold.

17. The method of claim 16 , wherein the processor determines, in real time, an amount of perfusion change in the tissue based on the synchronized curves at least in part by estimating the number of image pixels having fluorescence intensity above the threshold.

Assignments (18)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
SECURITY AGREEMENT (TERM) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0189 →
SECURITY AGREEMENT (REVOLVING) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2013
From: FERGUSON, T. BRUCE, JR.; CHEN, CHENG
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 030657/0022 →
Continuity (2)
Provisional Application 61662885 · Jun 21, 2012
Related Publication 20130345560A1 · Dec 26, 2013
Cited By (17)
US 12,186,055 US 12,207,909 US 12,207,916 US 12,239,409 US 12,303,235 US 12,329,511 US 12,357,194 US 12,374,128 US 12,390,124 US 12,464,215 US 12,482,557 US 12,490,904 US 12,502,097 US 12,514,468 US 12,541,867 US 12,635,938 US 12,678,051